APOLLO HOSPITALS ENTER. L vs NEULAND LAB LTD.

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and NEULAND LAB LTD. (NEULANDLAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, NEULAND LAB LTD. leads APOLLOHOSP vs NEULANDLAB on 9 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

65.36
P/E ratio
64.97
13.42
P/B ratio
13.37
0.11%
Dividend yield
0.17%
₹135.04
EPS
₹283.71

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
21.40%
18.00%
Return on capital
27.00%
15.00%
EBITDA margin
28.00%
7.94%
Net margin
17.99%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
19.31%
33.39%
Profit CAGR (3Y)
30.44%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.27L Cr
Market cap
₹23,643 Cr
₹25,228 Cr
Revenue
₹2,023 Cr
₹2,003 Cr
Net profit
₹364 Cr
0.90
Debt / equity
0.16
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 77.8% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
NEULAND LAB LTD.
  • + ["Company is expected to give good quarter", "Company has delivered good profit growth of 38.5% CAGR over last 5 years"]
  • ["Stock is trading at 13.4 times its book value", "Promoter holding has decreased over last 3 years: -3.50%"]
APOLLO HOSPITALS ENTER. L full analysis NEULAND LAB LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.